FINDEX Inc.

Tokyo Stock Exchange 3649.T

FINDEX Inc. Revenue for the year ending December 31, 2023: USD 36.79 M

FINDEX Inc. Revenue is USD 36.79 M for the year ending December 31, 2023, a 6.27% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

FINDEX Inc. Revenue for the year ending December 31, 2022 was USD 34.62 M, a -19.78% change year over year.
FINDEX Inc. Revenue for the year ending December 31, 2021 was USD 43.16 M, a 11.37% change year over year.
FINDEX Inc. Revenue for the year ending December 31, 2020 was USD 38.76 M, a -1.61% change year over year.
FINDEX Inc. Revenue for the year ending December 31, 2019 was USD 39.39 M, a 19.84% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Tokyo Stock Exchange: 3649.T

FINDEX Inc.

CEO	Mr. Teruo Aibara
IPO Date	March 23, 2011
Location	Japan
Headquarters	Asahiseimei-Otemachi Building
Employees	290
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

FINDEX Inc. engages in the research and development, manufacture, and sale of medical systems in Japan. The company's products include Claio, a medical imaging database management system for small, medium, and large size hospitals; and C-Note, a progress note system. It also offers DocuMaker, a document and data management system, which provides various input tools to enhance productivity in document creation; and GAP/GAP-screener, a gaze analyzing perimeter. In addition, the company develops applications for smart phone. It serves medical institutions, hospitals, and clinics. The company was formerly known as PSC Inc. and changed its name to FINDEX Inc. in November 2014. FINDEX Inc. was founded in 1985 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years